Metraipolis › archive › dc_74dfc29a2f8a

The building blocks of phage therapy: from lytic phage identification to preclinical validation against antimicrobial-resistant critical priority bacteria — Europe PMC PMID:42080567

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42080567
DOI
10.1128/spectrum.00507-26
License (as archived)
solo-consultazione
Archived
2026-10-08T11:55:56.661Z
SHA-256 of the archived text
bd910d8af0d34199b7cecf92d2752fc910d99bb01b566a74b8c5b48ed68d3002
Stable URL of this page
https://metraipolis.com/documento/dc_74dfc29a2f8a

How to cite

The building blocks of phage therapy: from lytic phage identification to preclinical validation against antimicrobial-resistant critical priority bacteria — Europe PMC PMID:42080567 — Europe PMC (en), https://europepmc.org/article/MED/42080567 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_74dfc29a2f8a (Metraipolis archive dc_74dfc29a2f8a, sha256 bd910d8af0d34199b7cecf92d2752fc910d99bb01b566a74b8c5b48ed68d3002)
BibTeX
@misc{dc74dfc29a2f8a,
  title = {The building blocks of phage therapy: from lytic phage identification to preclinical validation against antimicrobial-resistant critical priority bacteria — Europe PMC PMID:42080567},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42080567},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_74dfc29a2f8a; sha256 bd910d8af0d34199b7cecf92d2752fc910d99bb01b566a74b8c5b48ed68d3002},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42080567. Agents can read the archived copy with the MCP tool read_document.